Correlation between different levels of Her-2 protein expression and the efficacy of neoadjuvant therapy in Her-2 positive breast cancer
Her-2 (3+) expression correlates with superior pCR rates, underscoring the need for further research to refine patient selection for optimized targeted therapy benefits.
Authors
- Zhe Cui (ORCID: https://orcid.org/0000-0002-3345-5197)
- Wenhui Wang (ORCID: https://orcid.org/0000-0001-7198-4017)
- Hongbo Li (ORCID: https://orcid.org/0000-0002-9024-1574)
- Zhiyong Wang (ORCID: https://orcid.org/0000-0002-8043-0312)
- Yandong Li (ORCID: https://orcid.org/0000-0001-8153-081X)
Institutions
- Beihua University (CN)
- Jinhua Academy of Agricultural Sciences (CN)
- Jinhua Central Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-06
- DOI
- https://doi.org/10.3389/fonc.2025.1673234
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- People's Government of Jilin Province